The 2026 CABA trial results — showing creatine slowed Alzheimer's cognitive decline by 30% — change the conversation coaches can have with clients over 50. It's no longer just "take creatine for your session" — it's potentially a long-term brain health investment. Here's how to approach this topic professionally and responsibly.
Key Points for Coaches
- CABA trial 2026: creatine slowed cognitive decline 30% (in early-stage Alzheimer's patients)
- Creatine = triple case for 50+ clients: muscle, bone, and potentially brain
- How to discuss it: present data accurately, recommend 3-5g/day, refer to physician for clients with cognitive concerns
- What to avoid: claiming creatine prevents Alzheimer's in healthy adults — the data doesn't support that
Why this conversation is now relevant
The demographics of coaching clients are shifting. The 50+ segment is one of the fastest-growing in training demand — motivated by longevity, functional health, and prevention. These clients tend to be more health-informed, more attentive to long-term quality of life, and more likely to integrate supplements if the data is solid.
Creatine addresses their concerns on multiple fronts: muscle mass maintenance (sarcopenia prevention), bone health (studies show beneficial interaction with mechanical loading), and now potentially cognition. That's a richer case in 2026 than it was in 2025.
How to have this conversation correctly
Present the data precisely. "The CABA trial 2026 showed creatine slowed cognitive decline by 30% in patients diagnosed with early-stage Alzheimer's. This isn't a study in healthy adults — it's results in people already affected. But it suggests creatine plays a role in brain energy health, on top of its well-documented effects on muscle."
Recommend 3-5g/day. The validated dose remains 3-5g of creatine monohydrate daily, taken continuously. No mandatory loading phase. No cycling. Timing (pre/post workout) is minor — consistency is what matters.
Refer out for cognitive concerns. If a client expresses specific concerns about cognition or family history of Alzheimer's, that's outside a trainer's scope. Refer to their doctor — and mention that this new data exists to enrich the medical conversation if their physician hasn't heard about it yet.
Key takeaways
- The CABA trial 2026 enriches the creatine case for 50+ clients — without going beyond what the data supports.
- Triple validated case: muscle, bone, potentially brain. Three evidence-based reasons for 3-5g/day continuously.
- Right framing: "promising data, emerging research, not proven prevention in healthy adults."
- Business opportunity: position as a holistic health coach for the 50+ segment, not just a performance coach.